Navigation Links
Novavax Announces Poster Presentation at the 47th Annual Meeting of the IDSA
Date:10/29/2009

ROCKVILLE, Md., Oct.29 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that its abstract has been selected for poster presentation at the Infectious Diseases Society of America (IDSA) 47th Annual meeting being held in Philadelphia, Pennsylvania from October 29 - November 1, 2009.

Poster presentation: "Safety and Immunogenicity of a Recombinant Trivalent Seasonal Influenza Virus-Like Particle (VLP) Vaccine in Healthy Adults", Penny Heaton, M.D., Maria Allende, M.D., Kathy Lenhard, R.N., Mike Massare, PhD., and Mark Wolff, PhD. Saturday October 31, 2009 12:30 pm to 2:00 pm., Pennsylvania Convention Center, Poster Hall A.

About the 47th Annual Meeting of the IDSA

This conference will showcase abstract presentations containing outstanding, noteworthy science; and expanded roster of challenging interactive sessions; symposia on management of difficult pathogens, such as MRSA, Clostridium difficle, and drug-resistant mycobacteria, gram-negative bacillia and fungi; and the promises and challenges of new vaccines. The Special Plenary Session and Named Lectures will highlight important advancements as well as challenges in the world of infectious diseases. Additional information is available at www.idsociety.org.

About Novavax

Novavax, Inc. is a clinical-stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide, including H1N1, using advanced proprietary virus-like-particle (VLP) technology. The company produces potent VLP -based recombinant vaccines utilizing new and efficient manufacturing approaches. Novavax is committed to using its VLP technology to create country-specific vaccine solutions. The Company has formed a joint venture with Cadila Pharmaceutica
'/>"/>

SOURCE Novavax, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Novavax CEO to Present at BIO CEO & Investor Conference
2. Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
3. Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX)
4. Novavax CEO to Present at the World Vaccine Congress 2008
5. Novavax Opens Its First U.S. Vaccine Plant
6. Novavax Announces Release Date of 2008 First Quarter Financial Results and Investor Conference Call
7. Novavax Reports First Quarter 2008 Financial Results
8. Novavax CEO to Present at ACUMENBioFins 5th Annual Global Healthcare Conference
9. Novavax CEO to Present at FBR Capital Markets 12th Annual Spring Investor Conference
10. Novavax CEO to Present at Piper Jaffray Europe Conference, London, UK
11. Novavax to Join Russell 3000 Index

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...wire-FirstCall/--deCODE,genetics,Inc.(Nasdaq: DCGN...tionsbytheU.S.BankruptcyCourtfortheDistrictofDelaw...untarypetitionfor,reliefunderChapter11oftheUnitedS... TheordersissuedbytheBankruptcyCourtallowthecompan...proceedings.Inparticular,the,companyreceivedinteri...
(Date:11/24/2009)...bleEnergyCorp.announcedtodaythatthecompanyandtheOd...arded$2millionbyWashingtonState,sCommunityEconomic...hiptoconstructthestate,sfirstspecialtybiochemicalb...twillsignificantlyspeedthedevelopmentofourbiorefin...eMarbleEnergyCEOKellyOgilvie."WearegratefultotheGo...
(Date:11/24/2009)...all/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),theglobals...atithassubmittedaMAAtotheEuropeanMedicinesAgencyfo...herapyindevelopment,forthetreatmentofType1Gaucherd...lucerasealfathathasbeensubmitted,withprevious,subm...globalsupplyshortageofthecurrentlyapprovedandmarke...
(Date:11/24/2009)...Customers with Partners Validated to Process and A... , Ottawa, ON (PRWEB) Nov...r of products for biological sample collection, st...ew global partner program. The program offers sign...munity and is designed to help partners scale and ...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
... April 8 Amsterdam,Molecular Therapeutics (Eurone...apy, is, as of today, part of the newly created Ne... that NYSE Euronext has selected our company,for t...ndex will increase,the visibility of listed biotec...erformance of our sector.", The index is publishe...
...Milestone Payment, CARLSBAD, Calif., April 8, 200...ounced today that Bristol-Myers,Squibb Company (NY...ies,collaboration as a development candidate. As a...payment. The two companies have an ongoing,collabo...protein convertase,subtilisin kexin 9 (PCSK9). The...
...2008 For a woman facing,gynecologic cancer surger...choose a gynecologic oncologist, a physician who h...eatment of cancers of the female reproductive,syst...lose proximity to,other major organs in the abdome...e reproductive organs can easily spread to the bla...
Other Biology Technology:Amsterdam Molecular Therapeutics Part of Next Biotech Index 2BRISTOL-MYERS SQUIBB SELECTS ISIS DRUG TARGETING PCSK9 AS DEVELOPMENT CANDIDATE FOR PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASE 2BRISTOL-MYERS SQUIBB SELECTS ISIS DRUG TARGETING PCSK9 AS DEVELOPMENT CANDIDATE FOR PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASE 3BRISTOL-MYERS SQUIBB SELECTS ISIS DRUG TARGETING PCSK9 AS DEVELOPMENT CANDIDATE FOR PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASE 4Gynecologic Oncologist, With Board Certification in GYN Oncology, OB/GYN, and Surgery Offers Women With Cancer the Newest Treatment Frontier: the Surgical Robot 2
(Date:11/24/2009)...secrets of the earth,s history locked in its icy d...tle information on the environments that have been.... Now, a team of researchers from nine institution...$10 million dollars by the National Science Founda...rally. These scientists will drill through the Wes...
(Date:11/24/2009)... , The presence of increased body fat, and t...in the blood, hinders the loss and maintenance of ... University of Navarra conducted by Estbaliz Goyen... , The project, entitled "A nutrigenetic and nut... weight and inflammation," examines how the indivi...
(Date:11/23/2009)... Applied mathematicians dissected the morphology o...teristic long leaf with a saddle-like arc midsecti... simple cause of the lily,s fan-like shapeelastic ...ial growthwas revealed by using an equally simple ...g, a postdoctoral student at Harvard,s School of E...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2It can be predicted the reaction obese patients will have to a diet 2The cause behind the characteristic shape of a long leaf revealed 2Protect Your Pets During the Dog 28and Cat 29 Days of Summer 49391 1Protect Your Pets During the Dog 28and Cat 29 Days of Summer 49391 2Protect Your Pets During the Dog 28and Cat 29 Days of Summer 49391 3Teens Young Adults Need More Milk 49386 1Teens Young Adults Need More Milk 49386 2Aerobically unfit young adults on road to diabetes in middle age 49381 1Aerobically unfit young adults on road to diabetes in middle age 49381 2
...research has shown that resveratrol, a common diet...tion that leads to most types of breast cancer, su...cancer prevention. ,Resveratrol is a natural subst...in extract form as a dietary supplement at most ma...to prevent the first step that occurs when estroge...
...incident that led to the death of 26 dolphins near...heds new light on the extent of the problems facin...iversity of Exeter and Cornwall Wildlife Trust, pu...ion , has revealed a disturbing rise in the number...ornish beaches. The frequency of these mammals, co...
... patients with aggressive non-Hodgkin,s lymphoma i...ed chemotherapy regimen, researchers say. , At th...uropean Society for Medical Oncology, a group head...ts that giving these patients chemotherapy every 2...ed treatment outcomes. , The standard regimen in ...
Other Biology News:Researchers identify cancer preventive properties in common vitamin supplement 2Study shows rise in Cornwall's dolphin, whale and porpoise deaths 2New treatment approach promising for lymphoma patients in the developing world 2
Rabbit Anti-Human CHYMOTRYPSIN Polyclonal Antibody, Unconjugated from AbD Serotec
Captivate magnetic separator for six microtubes from Molecular Probes (Invitrogen)
Protein Purification Applications from Promega
...ibes the basic equipment required, principles and ... and detection. Methods such as radiometric and bi...included. Other topics covered are, the detection ...chains and the study of DNA binding of immobilized...
Biology Products: